Silicified Microcrystalline Cellulose (SMCC): Supplier Guide & Technical Deep Dive
Looking for a reliable silicified microcrystalline cellulose (SMCC) supplier? This page is designed for pharmaceutical formulators, procurement teams, and CDMOs seeking high-flow, direct compression excipients with consistent quality and regulatory compliance.
We are a professional silicified microcrystalline cellulose (SMCC) supplier and manufacturer, providing pharmaceutical-grade excipients for tablet formulation, direct compression systems, and solid dosage development worldwide.We also supply microcrystalline cellulose (MCC) and colloidal MCC gel for food and pharmaceutical applications.
This page covers not just our supply capabilities — it provides the technical depth that formulation scientists and procurement teams need to make confident decisions about SMCC grade selection, dosage, and application.
👉 Request SMCC datasheet, CoA, or sample
What Is Silicified Microcrystalline Cellulose (SMCC)?
Silicified microcrystalline cellulose (SMCC) is a co-processed pharmaceutical excipient produced by intimately combining microcrystalline cellulose (MCC) with a precisely controlled amount of colloidal silicon dioxide (typically 2% w/w). Unlike simple physical blends, the co-processing method creates a composite structure where silicon dioxide particles are embedded within and on the surface of MCC particles at the manufacturing stage.
This structural integration — not just surface coating — is what distinguishes SMCC from a manually blended MCC/SiO₂ mixture. The result is a material with fundamentally different powder behavior: superior flow, enhanced compressibility, and improved batch-to-batch consistency that a post-hoc blend cannot reliably replicate.
SMCC is listed in major pharmacopoeias including USP-NF and Ph. Eur., and is widely regarded as the benchmark co-processed excipient for direct compression tableting.
Key physicochemical characteristics:
- Appearance: White to off-white free-flowing powder
- Colloidal SiO₂ content: ~2% (co-processed, not blended)
- Moisture content: ≤5% (NMT, USP specification)
- pH (aqueous suspension): 5.0–7.5
- Insoluble in water, dilute acids, and most organic solvents
- Compendial status: USP/NF, Ph. Eur.
We are a professional:
- Silicified microcrystalline cellulose supplier
- SMCC manufacturer
- Pharmaceutical excipient supplier
- Direct compression excipient supplier
The Science Behind SMCC: Why Co-Processing Changes Everything
To understand why SMCC outperforms standard MCC in direct compression, it is necessary to understand how powder flow and compressibility work at the particle level.
How Colloidal Silicon Dioxide Modifies MCC Behavior
Microcrystalline cellulose is an excellent compressible excipient, but its flowability is limited by inter-particle cohesion — hydrogen bonding between hydroxyl groups on adjacent cellulose surfaces creates adhesive forces that resist free flow, especially at fine particle sizes.
Colloidal silicon dioxide (fumed silica, ~7–40 nm primary particle size) functions as a glidant by physically separating MCC particles and disrupting these cohesive interactions. When integrated through co-processing, the silica forms a partial coating on the cellulose surface, occupying the most active binding sites and reducing effective inter-particle contact area.
The outcome is measurable: Carr Index values for SMCC typically fall below 15 (indicating good-to-excellent flow), compared to 20–30+ for standard MCC grades of similar particle size. This difference is critical in high-speed rotary tablet presses, where consistent die filling depends on reliable powder flow from the hopper through the feed frame.
Compressibility: The Unexpected Benefit
A common assumption is that adding a hard, non-compressible material like silica would reduce tablet hardness. In SMCC, the opposite is observed. Because the silica reduces inter-particle friction, particles rearrange more efficiently during compression, leading to higher packing density and greater surface contact area under the punch force.
Additionally, the reduced internal stress in SMCC tablets (compared to over-lubricated MCC tablets) means that the plastic deformation capacity of cellulose is more fully utilized. Studies have demonstrated that SMCC tablets achieve higher hardness at equivalent compression force, and maintain higher hardness in the presence of magnesium stearate — a critical advantage, as lubricant sensitivity is one of the main failure modes in direct compression formulation.
SMCC vs MCC: A Formulator’s Comparison
The choice between SMCC and standard MCC is not simply a matter of “better vs. worse” — it depends on the specific challenges of the formulation. Below is a technical comparison across the parameters that matter most in tablet development.Compared with standard MCC excipients, SMCC provides better flowability and compressibility.
| Parameter | SMCC | Standard MCC (e.g., PH-102) |
|---|---|---|
| Flowability (Carr Index) | ≤15 (Good–Excellent) | 20–30 (Fair–Poor) |
| Compressibility | Higher tablet hardness per force unit | Good, but lower than SMCC |
| Lubricant sensitivity | Low — maintains hardness with MgSt | Moderate — hardness drops with over-lubrication |
| Content uniformity (low-dose APIs) | Excellent — reduced segregation | Good — may require extra blending steps |
| High-speed tableting suitability | High — reliable die filling | Moderate — may require flow aids |
| Moisture sensitivity | Similar to MCC | Standard baseline |
| Disintegration | Good (comparable to MCC) | Good |
| Regulatory status | USP/NF, Ph. Eur. | USP/NF, Ph. Eur., JP |
| Cost | Slightly higher than standard MCC | Lower baseline cost |
Practical conclusion: If your formulation involves high-speed tableting, a low-dose API requiring tight content uniformity, or a blend that has shown lubricant sensitivity, SMCC offers a significant technical advantage over standard MCC. For simpler formulations with adequate flow, standard MCC remains cost-effective.
👉 Related: Colloidal Microcrystalline Cellulose (MCC Gel)
👉 Related: Microcrystalline Cellulose (MCC) Supplier
SMCC Grade Selection by Application
SMCC is commercially available in multiple particle size grades, analogous to the MCC PH-101/PH-102/PH-200 range. Grade selection primarily affects flow rate, bulk density, and suitability for different tableting equipment.
| SMCC Grade | Mean Particle Size | Typical Application |
|---|---|---|
| SMCC 50 | ~50 µm | Formulations requiring finer particle size, blending with fine API powders, improved content uniformity |
| SMCC 90 | ~90 µm | General direct compression, standard tablet presses, balanced flow and compressibility |
Grade selection should be confirmed through bulk density measurement, flow testing (Carr Index / Hausner Ratio), and compaction simulation (e.g., Heckel analysis or compaction simulator) at the formulation development stage.
Formulation Guidance: How to Use SMCC Effectively
Recommended Dosage Level
SMCC is typically used at 20%–80% by weight of the total tablet blend in direct compression systems. The optimal level depends on the API loading, required tablet hardness, and disintegration target. For high-drug-load formulations (API > 50%), SMCC at 20–30% can still provide meaningful flowability improvement. For low-API formulations, SMCC serves as the primary matrix former at 50–80%.
Compatibility with Other Excipients
SMCC is generally compatible with most pharmaceutical excipients. Key considerations:
- Lubricants: SMCC shows significantly lower sensitivity to magnesium stearate over-lubrication compared to standard MCC. Recommended MgSt level remains 0.25–1.0% w/w with standard blending time (3–5 min).
- Disintegrants: SMCC is compatible with croscarmellose sodium (Ac-Di-Sol), sodium starch glycolate, and crospovidone. Disintegrant level should be confirmed by dissolution testing.
- APIs: SMCC is chemically inert and non-reactive with most APIs. For moisture-sensitive compounds, note that SMCC carries inherent moisture similar to MCC (~3–5%); packaging and storage controls apply.
Direct Compression Protocol
For a standard direct compression blend using SMCC:
- Screen SMCC and API through an appropriate mesh (typically 30–40 mesh) to break agglomerates
- Co-mill API with a portion of SMCC if API particle size is very fine (geometric dilution step)
- Blend API + SMCC + disintegrant in a tumble blender (10–15 min)
- Add lubricant (MgSt) and blend for 3–5 min — do not over-blend
- Verify blend uniformity (RSD ≤ 5.0% target) before compression
Pharmaceutical Applications of SMCC
SMCC is used across a broad range of solid dosage formats and therapeutic categories:
- Tablet direct compression — the primary application; replaces wet granulation for many formulations, reducing manufacturing complexity and cost
- Low-dose high-potency formulations — improved content uniformity reduces risk of blend segregation for APIs dosed at <10 mg
- Orally disintegrating tablets (ODTs) — SMCC provides a smooth mouthfeel and adequate hardness at low compression forces
- Nutraceutical and dietary supplement tablets — SMCC performs well as a matrix filler in botanical and vitamin formulations
- Chewable tablets — compatible formulations where smooth texture is valued
Why Choose Us as Your SMCC Supplier
As an established silicified microcrystalline cellulose manufacturer and supplier, we provide more than material supply — we support your formulation from development through commercial scale.
- ✔ Consistent quality — full CoA, particle size distribution, flow data with every batch
- ✔ Pharmacopoeial compliance — USP/NF and Ph. Eur. specification compliance as standard
- ✔ Multiple grades available — SMCC 50 and SMCC 90 in stock
- ✔ Technical support — formulation consultation, grade selection guidance, troubleshooting
- ✔ Flexible supply — sample quantities through commercial bulk, with reliable lead times
- ✔ Global export experience — compliance documentation for regulated markets (US, EU, Asia-Pacific)
Technical Specifications
| Parameter | Specification |
|---|---|
| Product Name | Silicified Microcrystalline Cellulose (SMCC) |
| Appearance | White to off-white powder |
| SiO₂ Content | ~2% w/w (co-processed) |
| Loss on Drying | ≤5.0% |
| pH (1:10 suspension) | 5.0–7.5 |
| Heavy Metals | ≤10 ppm |
| Microbial Limits | Per USP/Ph. Eur. pharmaceutical excipient standards |
| Available Grades | SMCC 50, SMCC 90 |
| Pharmacopoeial Status | USP/NF, Ph. Eur. |
| Packaging | 25 kg fiber drums, PE inner bag |
| Storage | Cool, dry conditions; protect from moisture |
Related Pharmaceutical Excipients
- 👉 Microcrystalline Cellulose (MCC) — PH-101, PH-102, PH-200
- 👉 Colloidal MCC (MCC Gel) — Suspension stabilizer
- 👉 Carboxymethyl Cellulose (CMC) — Binder and stabilizer
- 👉 HPMC Pharma Grade — Controlled release matrix
Frequently Asked Questions
What is the difference between SMCC and a physical blend of MCC + colloidal silica?
A physical blend simply mixes the two materials together; the silica does not integrate into the MCC particle structure. Co-processed SMCC embeds silicon dioxide within the MCC matrix during manufacturing, producing a homogeneous composite particle. Physical blends are less consistent, tend to segregate, and do not deliver the same flowability or compressibility improvements. This is why SMCC is a defined compendial excipient and physical blends are not considered equivalent for regulatory purposes.
Is SMCC suitable for moisture-sensitive APIs?
SMCC has a similar equilibrium moisture content to standard MCC (~3–5% under typical warehouse conditions). For moisture-sensitive APIs, appropriate packaging (sealed HDPE containers, silica desiccant inserts) and controlled storage conditions are required — the same precautions apply to standard MCC-based formulations. A specific compatibility study between the API and SMCC is recommended during development.
Can SMCC replace MCC in an existing tablet formulation without revalidation?
Substituting SMCC for MCC in an existing approved formulation typically constitutes a formulation change that requires regulatory notification or prior approval depending on the market and change classification. From a technical standpoint, the compression and flow behavior will differ — in most cases favorably — but compaction force, tablet hardness, and dissolution profiles should be re-verified. We recommend pilot-scale trials before any scale-up decision.
What viscosity grade or particle size should I choose?
For most standard tablet formulations using direct compression, SMCC 90 (mean ~90 µm) is the starting point. If your API is very fine (<20 µm) and content uniformity is a concern, SMCC 50 may reduce segregation risk due to closer particle size matching. Our technical team can assist with grade selection based on your formulation brief.
Are you a SMCC supplier or manufacturer?
We are both. We manufacture silicified microcrystalline cellulose in-house and supply directly to pharmaceutical manufacturers and contract development organizations (CDMOs) globally. Direct manufacturing means we control quality at every step and can respond quickly to supply or specification queries.
What documentation is available for regulatory submissions?
We provide full Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS/SDS), DMF reference support where applicable, and technical data packages for regulatory filing support. Please contact us to discuss your specific documentation requirements.
What is silicified microcrystalline cellulose used for?
SMCC is mainly used as a direct compression excipient in tablet formulation, improving flowability, compressibility, and content uniformity.
Who are the leading SMCC suppliers?
Leading SMCC suppliers provide pharmaceutical-grade material with USP/NF and Ph. Eur. compliance, consistent particle size distribution, and technical support.
Get SMCC Price, Samples & Technical Support
Looking for a reliable silicified microcrystalline cellulose supplier with consistent quality and fast delivery?
- 📄 SMCC datasheet, CoA, and regulatory documents
- 🧪 Free samples for formulation testing
- 📦 Bulk supply with competitive pricing
- 🔬 Technical support for direct compression formulation